U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H22ClFN4O4
Molecular Weight 484.907
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ERIBAXABAN

SMILES

CO[C@@H]1C[C@@H](N(C1)C(=O)NC2=CC=C(Cl)C=C2)C(=O)NC3=C(F)C=C(C=C3)N4C=CC=CC4=O

InChI

InChIKey=QQBKAVAGLMGMHI-WIYYLYMNSA-N
InChI=1S/C24H22ClFN4O4/c1-34-18-13-21(30(14-18)24(33)27-16-7-5-15(25)6-8-16)23(32)28-20-10-9-17(12-19(20)26)29-11-3-2-4-22(29)31/h2-12,18,21H,13-14H2,1H3,(H,27,33)(H,28,32)/t18-,21-/m1/s1

HIDE SMILES / InChI

Description

Eribaxaban (PD 348292) is an orally efficacious factor Xa inhibitor. It demonstrated antithrombotic efficacy in animal models. Pfizer was developing eribaxaban for the treatment of venous thrombosis.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

PubMed